Application of micro capillary blood sampling in an anti‐doping setting
Drug Testing and Analysis · 2024-08 · 16 (8) · 835-840
DOI: 10.1002/dta.3603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 20.11.2023. Verfasst von Laura Lewis und 8 weiteren Autor:innen. Beteiligte Einrichtung: United States Anti-doping Agency, Colorado Springs, Colorado, USA. Hauptthemen laut MEDLINE: Doping in Sports, Blood Specimen Collection, Substance Abuse Detection, Capillaries. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Blood collection is an important facet of anti‐doping testing, forming the basis of the Athlete Biological Passport (ABP). Traditional blood collection via venipuncture can be uncomfortable for athletes, especially those who are tested frequently or close to competition. Athletes may also have negative perceptions of venipuncture due to past experiences or the risks of adverse health events such as bruising, hematomas, syncope, and general discomfort that has the potential to affect performance. Advances in capillary whole blood collection technology now affords the ability to collect micro‐volumetric capillary whole blood from the upper arm (or other suitable vascular location such as the abdomen) that is “needle‐free” and virtually painless using devices such as the Tasso+. The present study extends previous work, by collecting microliter capillary whole blood samples via the Tasso+ EDTA device in an official anti‐doping setting prior to competition, as well as requiring temperature‐monitored cold chain shipping by air to the laboratory before analysis. Fifty‐eight matched capillary and venous blood samples were collected under official doping control conditions by certified Doping Control Officers. No impact of sample shipment by air under cool conditions was observed on sample integrity. Provided that no visible clots were identified prior to analysis, capillary and venous blood samples showed excellent laboratory agreement for all CBC parameters, with the exception of platelets. Micro capillary blood collection provides a valid alternative to venous blood collection for ABP purposes, with the advantage of providing a more athlete‐friendly experience, particularly close to competition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- United States Anti-doping Agency, Colorado Springs, Colorado, USA.
- Sports Medicine Research Testing Laboratory, Salt Lake City, Utah, USA.
- Bryam Hills, Armonk, New York, New York, USA.
- Athletics Integrity Unit, Monaco.
ORCID-Profile: Jenna Goodrum, Matthew Fedoruk, Geoff Miller
Zitieren
APA
Lewis, L., Goodrum, J., Cai, C., Muir, T., Boutard, K., Capdevielle, T., Longo, S., Fedoruk, M., & Miller, G. (2024). Application of micro capillary blood sampling in an anti‐doping setting. Drug Testing and Analysis, 16(8), 835-840. https://doi.org/10.1002/dta.3603
Vancouver
Lewis L, Goodrum J, Cai C, Muir T, Boutard K, Capdevielle T, et al. Application of micro capillary blood sampling in an anti‐doping setting. Drug Testing and Analysis. 2024;16(8):835-840. doi:10.1002/dta.3603
BibTeX
@article{Lewis2024,
author = {Lewis, Laura and Goodrum, Jenna and Cai, Calvin and Muir, Tessa and Boutard, Kristin and Capdevielle, Thomas and Longo, Stefano and Fedoruk, Matthew and Miller, Geoff},
title = {Application of micro capillary blood sampling in an anti‐doping setting},
journal = {Drug Testing and Analysis},
year = {2024},
volume = {16},
number = {8},
pages = {835--840},
doi = {10.1002/dta.3603}
}
EUVIMED